Clinical Trials Directory

Trials / Completed

CompletedNCT01591538

Multi-Antibiotic Resistance Carriage in Gut Flora

Prevalence Study Evaluating the Acquisition of Carriage of Resistant Bacteria in the Gut Flora in Volunteers From French Armed Forces Coming Back From External Operations

Status
Completed
Phase
Study type
Observational
Enrollment
272 (actual)
Sponsor
Da Volterra · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Prevalence Study evaluating the acquisition of carriage of multidrug-resistant Gram-negative bacteria (MDRGNB) in the gut flora in volunteers of French Armed Forces staying from 4 to 6 months outside France.

Detailed description

Emergence of MDRGN bacteria is blowing worldwide up leading to therapeutical failure in hospitalized patients with severe infections, as well as in outpatients with community-acquired infections such as UTI. Variation in prevalence exists across countries and regions. Travels outside own country of residence, like France, whatever the duration (short or long)or the reason (professional or leisure), are known risk factors for acquiring and disseminating MDRGN bacteria. Digestive carriage of multidrug-resistant Enterobacteriaceae could be a source of infection for the host as well as a source of dissemination. Qualitative and quantitative gut colonization by MDRGNB is poorly studied in non-hospitalized people who stayed for a few months out of France. The total amount of multidrug-resistant Enterobacteriaceae influences the spread of the dissemination. In our knowledge, no clinical study has been carried out to qualify and quantify gut colonization by MDRGNB in volunteers after staying 4-6 months outside country of residence such as France. A specific microbiological method will be evaluated in this study.

Conditions

Timeline

Start date
2012-03-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-05-04
Last updated
2014-05-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01591538. Inclusion in this directory is not an endorsement.